Nasdaq

Roche: FDA Approves Cobas SARS-CoV-2 & Influenza A/B Test Under Emergency Use Authorization

(RTTNews) - Roche (RHHBY) announced the cobas SARS-CoV-2 & Influenza A/B Test for use on the cobas 6800/8800 Systems has received Emergency Use Authorization from the FDA. The test is intended for the ...
Pharm Exec

FDA Grants Emergency Use Authorization to Roche’s Cobas Liat SARS-CoV-2, Influenza A/B, & RSV Nucleic Acid Test

The cobas is classified as a four-in-one molecular test that can identify SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus from a single nasopharyngeal or anterior nasal swab ...
Pharmabiz

US FDA grants Emergency Use Authorization to Roche’s cobas SARS-CoV-2 &influenza A/B test for use on the cobas 6800/8800 Systems

Roche announced that the cobas SARS-CoV-2 & Influenza A/B Test for use on the cobas 6800/8800 Systems has received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA).
Pharmabiz

Roche launches new blood gas analyzer cobas b 123 POC systems

Roche announced to introduce its new blood gas analyzer, the cobas b 123 POC systems, in Europe and several markets in Latin America, Middle East, Africa and the Asia-Pacific region. The cobas b 123 ...
technologynetworks

Kingston Hospital Delivers Point of Care Testing Excellence

Kingston Hospital NHS Trust ensures rapid and reliable results for blood gases and other critical care parameters using Roche cobas b 221 blood gas analysers. Easy to use and requiring minimal ...